Table 2 The C-index of the prognostic model, TNM stage, and treatment for prediction of NV-HCC OS in the development cohort and validation cohort
Factors | C-index (95% CI) | P |
|---|---|---|
For development cohort | ||
 Prognostic model | 0.759 (0.723–0.797) |  |
 TNM stage | 0.708 (0.663–0.753) |  |
 Treatment | 0.630 (0.582–0.677) |  |
 Prognostic model vs TNM stage |  | 0.021 |
 Prognostic model vs treatment |  | < 0.001 |
For validation cohort | ||
 Prognostic model | 0.796 (0.737–0.855) |  |
 TNM stage | 0.721 (0.647–0.795) |  |
 Treatment | 0.700 (0.630–0.770) |  |
 Prognostic model vs TNM stage |  | 0.022 |
 Prognostic model vs treatment |  | 0.029 |